Jeffrey James Ross - 23 Jun 2021 Form 3 Insider Report for Miromatrix Medical Inc.

Role
Chief Executive Officer
Signature
/s/ Elise B. Houser, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
23 Jun 2021
Net transactions value
$0
Form type
3
Filing time
23 Jun 2021, 18:36:15 UTC
Next filing
18 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MIRO Common Stock 203,750 23 Jun 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MIRO Series B Preferred Stock 23 Jun 2021 Common Stock 4,400 $7.50 Direct F1
holding MIRO Employee Stock Options (right to buy) 23 Jun 2021 Common Stock 35,438 $1.25 Direct F2
holding MIRO Employee Stock Option (right to buy) 23 Jun 2021 Common Stock 37,500 $1.25 Direct F2
holding MIRO Employee Stock Option (right to buy) 23 Jun 2021 Common Stock 41,250 $3.75 Direct F2
holding MIRO Employee Stock Option (right to buy) 23 Jun 2021 Common Stock 43,750 $3.75 Direct F2
holding MIRO Employee Stock Option (right to buy) 23 Jun 2021 Common Stock 33,688 $3.75 Direct F2
holding MIRO Employee Stock Option (right to buy) 23 Jun 2021 Common Stock 39,375 $3.75 Direct F2
holding MIRO Employee Stock Option (right to buy) 23 Jun 2021 Common Stock 100,000 $3.75 Direct F2
holding MIRO Employee Stock Option (right to buy) 23 Jun 2021 Common Stock 68,714 $3.75 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 N/A
F2 Fully vested.
F3 34,357 shares vested; 34,357 will vest on May 30, 2022.